Skip to content

Industries · Manufacturing & Industrial

Buyers judge the plant by its licences and papers before they judge the product.

A start-up founder wants a night cream made under a new label. A PCD partner is comparing three companies for a tablet range. A hospital purchase officer needs a glove that will pass inspection. A formulator is qualifying a second source for a molecule. Each begins the same way, by asking to see the licence, the certificate or the test document before anything else is discussed.

Scope, fee, reporting and term are agreed in writing after we have read your brief and spoken to you.

Realistic editorial illustration of chemical manufacturers at work in India

In one paragraph

Pharma and personal care manufacturers make medicines, active ingredients, cosmetics, soaps, creams and medical consumables, for their own brands or under another brand's name. GullySales looks at what a buyer can verify about your plant, how each enquiry, sample and trial batch is followed, and what your pages may say within rules that differ by product and body.

What these six trades share is that every product is made under rules on manufacture, labelling and promotion, and that a buyer who cannot verify the plant does not order. They differ in who the buyer is. Cosmetic and personal care makers serve brand owners and salons, pharmaceutical makers serve stockists, franchise partners and tender buyers, contract makers serve marketing companies, and API and consumable makers serve formulators and hospital stores.

Last updated 18 Oct 2026. Rules on what you may advertise differ by trade and change. This page describes them in general terms only, so check the current position with your own adviser or regulator.

6 kinds of business

Each kind of business in pharma & personal care manufacturing sells a little differently.

Open the page closest to yours for how its buyers choose and what we would fix first.

Cosmetic manufacturers

Founders ask for rates without a brief, small brands balk at the minimum order, and sample rounds run long. The route from brief to sample to repeat batch needs tracking, and past work cannot be shown by name.

Read the page for cosmetic manufacturers

Personal care product manufacturers

Work is made under other people's labels, so the site has to show the range the plant can run, from soap and shampoo to creams and hair oil. A costed quote that arrives late loses the buyer.

Read the page for personal care product manufacturers

Pharmaceutical manufacturers

Franchise enquiries mix serious partners with people collecting price lists, partners go quiet after the first orders, and tender follow-up rests on one person. Rules on promoting medicines limit what a page can say.

Read the page for pharmaceutical manufacturers

API manufacturers

A request for documents starts an email chain, and a trial can go silent after it begins. Sales and regulatory teams need one shared record of the papers that exist for each molecule, and your regulatory team checks every claim.

Read the page for api manufacturers

Contract pharmaceutical manufacturers

Brand owners hand over a product and a name, yet a rate sheet shows only the price per tablet. Enquiries that arrive as one-line calls, with no batch size or pack, are hard to cost, and clients cannot be named.

Read the page for contract pharmaceutical manufacturers

Medical consumable manufacturers

Hospitals buy through distributors, so the user does not hear your name. Samples reach the store and stop there, tender bids fail on missing papers, and buyers think one glove or syringe is much like another.

Read the page for medical consumable manufacturers

What they share

What usually goes wrong across pharma & personal care manufacturing.

Whichever of these you run, you will probably recognise most of them.

  • “The first message tells us little about who will order”

    A call asks for a rate on twenty products, a price list, or a sample, with no brief, batch size, molecule or volume behind it. Serious buyers and people gathering quotes look alike until time has been spent on both.

  • “A sample or trial batch leaves and nothing comes back”

    Sample rounds, sachets, a certificate of analysis with a trial quantity, a box sent to a hospital store, a first order to a new partner: all are followed by silence, and nobody on our side asks what happened.

  • “The papers a buyer asks for sit in three departments”

    Licences, certificates, test documents and tender forms each live with a different person. Every request starts a chase, and a document that is out of date is found only when the buyer reads it.

  • “Our website is a list of products or a photo of the factory”

    A molecule list, a dosage-form list, a catalogue image or a plant photo does not tell a buyer why to choose this plant over the next licensed one.

  • “The user does not know our name”

    The pack carries a brand owner's name, or the product reaches its user through a stockist, a distributor or a trader. We cannot tell why a customer switched, because we never knew who the customer was.

  • “Nobody has settled what sales may say”

    Rules on promoting medicines, on cosmetic claims and on labelling are strict, and the sales team and the regulatory team have never agreed the lines. Marketing says almost nothing, or a promise is made that the regulatory file does not support.

Where to start

What to fix first in pharma & personal care manufacturing.

In the order we would look at them. Your own enquiry records may change the order, and we would say so.

  • Add a short brief form that asks for the product type, pack, batch size, market and current supplier, and ask for it before any costing starts.
  • Keep the licences, certificates and test documents a buyer asks for in one organised set that your regulatory team owns and keeps current.
  • Give every sample and trial batch one named owner who asks the buyer what was tested, what needs to change and when a decision is due.
  • Agree with your regulatory adviser, once and in writing, what your pages may state, then publish product pages inside those lines.
  • Replace the product list with pages organised by what the plant can make or supply: dosage forms, product types, pack options and what a buyer receives as a sample.
  • Record every partner, distributor and brand owner with the date of the first order, the latest order and the person who last spoke to them.

FAQ

Questions about pharma & personal care manufacturing.

Not here? More answers, or ask on WhatsApp.

Can we show our contract clients' names?
Only with their written permission. A client's name is its own business, so show the plant, the range, the standards you hold and the batch sizes you run, and a buyer can judge you without a client list.
What can we say about what a product does?
Rules on medicines, cosmetics, active ingredients and medical devices differ by product and by body, and promotion of medicines is tightly limited. Describe the company, the range and the standards you hold, avoid claims about results, and have your regulatory adviser read every page before it goes live.
How do we separate serious enquiries from people collecting price lists?
Ask the same few questions of everyone: what product, what quantity, for which market and with which licence. A buyer who answers has a plan. One who does not still gets a short, polite reply, but the call goes to someone else.
Should we list on IndiaMART or similar marketplaces?
They bring enquiries, including from traders and people comparing rates. Use a listing as one source, keep the wording inside the rules for your product, and keep your own website so a serious buyer can check licences and range.
How do we decide which enquiry gets a call first?
Decide by what the enquiry states. A message with a product, a batch size and a market goes to a call the same day. One with a single line goes first to a short reply asking for those details.
How soon will we see results?
It depends on what is being changed and how many of the people who matter see it. After we have read your brief and spoken to you, we say what we would expect to move first and how it will be measured against the baseline. Nothing here is guaranteed.
Who will actually do the work?
The person you speak to before anything starts. We work from one office in Nagarbhavi, Bengaluru, with no account managers in between.
What do you need from us?
Your brief, and a conversation. After that, access to whatever the work touches, such as your profiles, your website or your accounts, and time with the people who can answer our questions.
What if we are not happy with the work?
Tell us and the plan changes. Everything is reported against the baseline, so a number that is not moving is visible to both sides. The term is in your written scope, and the refund and cancellation policy sets out the rest.

Your brief

Tell us what you need, and we will read it before we call.

Eight short steps about your business, what you want and who decides. Most questions are a tap, and you can skip any you would rather answer on the call.

Your next practical step

Tell us what you are trying to grow, and we will read it before we call.

Eight short steps, mostly taps. Skip anything you would rather answer on the call.